IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.90
Bid: 36.25
Ask: 37.10
Change: 0.00 (0.00%)
Spread: 0.85 (2.345%)
Open: 36.70
High: 37.00
Low: 36.50
Prev. Close: 36.675
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: H&T Group, China Medical, Fyffes...

Wed, 13th May 2009 09:20

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate."The principal reason for the strong performance is the sustained gold price which has benefitted the Group's retail sales, auctions, scrap and gold purchases. The Group is also pleased with the continuing success of the store expansion programme," said H&T.Chinese pharmaceutical sales, marketing & research firm China Medical saw pre-tax profit rise to $19.5m from $10.3m before on sales 40% to $72.6m. Total dividend for year will be $0.15p share against $0.10p each. "I am delighted to report on a second outstanding year for CMS as a public company despite the challenging economic environment seen domestically and globally. We have achieved sustained and steady growth in sales and profits, and I am pleased that," said the group.Fruit importer and distributor Fyffes said trading in teh year to date has been in line with expectations and it remains on course to achieve its earnings target for the year. Previously it has taargeted an adjusted EVIB for 2009 in the range of €14m-€18m. Shares in Futura Medical fell back after the consumer healthcare products firm reported a delay in achieving regulatory approval for CSD500, a condom designed to help men maintain an erection.Futura, which is developing the condom with Durex firm SSL, hoped the product would be awarded a CE mark soon after EU authorities expressed a positive opinion on the product's pharmaceutical aspects. However, SSL's decision to move condom manufacturing to Asia means the EU has asked for additional manufacturing data on CSD500 and Futura now expects to receive CE marketing authorisation around the end of the year.Public sector focused support services company Tribal said trading in 2009 has been in line with expectations.The sales pipeline remains healthy while committed income now stands at £210m, up from £139m at the beginning of the year. Printing group Communisis shot up after it announced a contract to T-Mobile UK 's marketing division with a suite of printing services. The contract was awarded to Communisis following a tender process. Housebuilder McInerney said trading conditions during 2009 in its key markets of Ireland and UK continue to be challenging due to low consumer confidence, restricted access to mortgages and the uncertain financial climate."We remain focused on generating positive cash flow and the implementation of additional efficiencies in the Group's cost base. Management's key objective is to rebuild shareholder value in the medium term," it said.Shares in Rheochem slipped back down again today after the oil and gas firm released a statement saying it knew of no reason behind its sudden share price rise earlier in the day. The group said the strategic review of its oil and gas assets are still ongoing and no decision has been reached.
More News
30 Jun 2010 08:56

Futura Medical Signs Development Deal With GlaxoSmithKline

LONDON (Dow Jones)--Pharmaceutical company Futura Medical PLC (FUM.LN) Tuesday said it signed a deal with GlaxoSmithKline PLC's (GSK.LN) cosumer healthcare unit to develop a painkiller. GlaxoSmithKline will be responsible for the clinical and regulatory development of Futura's TR100 and Futura w

Read more
12 May 2010 12:36

Small caps round-up: Aurelian, Cineworld, Greggs...

Eastern Europe focused oil and gas explorer and producer Aurelian today reconfirmed "steady" progress against all targets set out in October's strategy document. "We are on track to spud our first two high impact wells in line with our milestones; in June we commence the drilling of the first multi

Read more
2 Mar 2010 12:38

Small caps round-up: Share, Jetion Solar, Futura Medical...

Share, parent company of retail stockbroker The Share Centre, lifted profits last year to £2.35m from £1.46m on turnover of £14.1m, up from £12m. There was a significant increase in retail investor activity - especially online with deal volumes up by 75% on 2008, Share said. The interim dividend is

Read more
16 Dec 2009 08:43

Futura a step closer to TPR100 deal

Consumer healthcare product developer Futura Medical is in talks with a major pharmaceutical company on a licensing deal for its pain relief product, TPR100. The company interested in licensing TPR100 is the same one with which Futura announced an evaluation agreement in July 2009. Futura has rece

Read more
12 Nov 2009 14:32

Small caps round-up: Syntopix, Atlantic Coal, Brady...

Drug developer Syntopix shares rallied as it reported positive phase 2 results for its lead dermatological compound SYN0126, for the treatment of acneic skin. Following the results, Syntopix has decided to focus its development efforts around three specific core compounds: SYN0126, SYN1113 and SYN

Read more
10 Nov 2009 09:22

Production changes in line for Futura condom

Futura Medical said a number of potential improvements to the production process of its ‘erectogenic’ condom have been identified by Durex condom maker SSL International. The proposed changes to the manufacturing process at SSL’s manufacturing facility in India have the potential to improve product

Read more
23 Sep 2009 13:10

Small caps round-up: Lifeline Scientific, Autologic, Bond...

The market liked Lifeline Scientific's maiden interim operating profit of $73,000 versus last year's loss of $3.1m, as the sale of 11 new LifePort kidney transporters helped revenue jump 123% to $7.75m. 'Trading was in-line with management's expectations during the first half and the board is confi

Read more
20 Jul 2009 08:35

Small caps round-up: Abbeycrest, Synchronica, Futura...

Jewellery maker Abbeycrest said it is performing in line with expectations as it undergoes a turnaround plan. The unbranded jewellery business is delivering much improved results on a significantly reduced turnover, the firm said. The brands division is making good progress with its higher margin b

Read more
10 Jun 2009 08:27

Small caps round-up: Intelligent Environments, LPA Group, Mobile Streams...

Banking software firm Intelligent Environments said trading in the current year to date has been robust. The group said it has experienced strong demand from new and existing customers to launch platforms to attract and retain retail deposits online. "Our strategy to develop a long term recurring r

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.